SCOPUS 정보 검색 플랫폼

Volumn 9, Issue 1, 1997, Pages 54-58

Antisense therapy: Therapeutic magic bullet or theoretical dream?

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; RIBOZYME;

CANCER; DRUG TARGETING; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030957660 PISSN: 09366555 EISSN: None Source Type: Journal
DOI: 10.1016/S0936-6555(97)80063-5 Document Type: Article

Times cited : (4)

References (12)

1
- 0041582974
- Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
- Zamecnik PC, Stephenson ML, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 1978;75:280-4.
- (1978) Proc Natl Acad Sci USA , vol.75 , pp. 280-284
- Zamecnik, P.C.¹ Stephenson, M.L.²

2
- 0028834582
- Oligonucleotide-mediated modulation of mammalian gene expression
- Scanlon KJ, Ohta Y, Ishida H, et al. Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 1995;9:1288-96.
- (1995) FASEB J , vol.9 , pp. 1288-1296
- Scanlon, K.J.¹ Ohta, Y.² Ishida, H.³

3
- 0027314371
- Antisense technology for cancer therapy: Does it make sense?
- Carter G, Lemoine NR. Antisense technology for cancer therapy: does it make sense? Br J Cancer 1993;67:869-76.
- (1993) Br J Cancer , vol.67 , pp. 869-876
- Carter, G.¹ Lemoine, N.R.²

4
- 0027933139
- Antisense therapy for malignant disease
- O'Brien SG, Kirkland MA, Goldman JM. Antisense therapy for malignant disease. Eur J Cancer 1994;30A:1160-4.
- (1994) Eur J Cancer , vol.30 A , pp. 1160-1164
- O'Brien, S.G.¹ Kirkland, M.A.² Goldman, J.M.³

5
- 0028019410
- Gene inhibition using antisense oligodeoxynucleotides
- Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994;372:333-5.
- (1994) Nature , vol.372 , pp. 333-335
- Wagner, R.W.¹

6
- 0028806487
- Does antisense exist?
- Stein C. Does antisense exist? Nature Med 1995;1:1119-21.
- (1995) Nature Med , vol.1 , pp. 1119-1121
- Stein, C.¹

7
- 0027058137
- Ablation of transplanted HTLV-1 tax-transformed tumours in mice by antisense inhibition of NF-κB
- Kitajima I, Shinohara T, Minor T, et al. Ablation of transplanted HTLV-1 tax-transformed tumours in mice by antisense inhibition of NF-κB. Science 1992;258:1792-5.
- (1992) Science , vol.258 , pp. 1792-1795
- Kitajima, I.¹ Shinohara, T.² Minor, T.³

8
- 0003227962
- In vivo suppression of B cell lymphoma with BCL-2 antisense oligonucleotides
- Pocock C, Al-Mahdi N, Hall P, et al. In vivo suppression of B cell lymphoma with BCL-2 antisense oligonucleotides. Blood 1993;92(suppl):200A.
- (1993) Blood , vol.92 , Issue.SUPPL.
- Pocock, C.¹ Al-Mahdi, N.² Hall, P.³

9
- 0022555857
- Biological catalysis by RNA
- Cech LR, Bass BL. Biological catalysis by RNA. Annu Rev Biochem 1993;55:599-629.
- (1993) Annu Rev Biochem , vol.55 , pp. 599-629
- Cech, L.R.¹ Bass, B.L.²

10
- 0028169597
- Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme
- Holm PS, Scanlon KJ, Dietel M. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. Br J Cancer 1994;70:239-43.
- (1994) Br J Cancer , vol.70 , pp. 239-243
- Holm, P.S.¹ Scanlon, K.J.² Dietel, M.³

11
- 0028110360
- Ribozyme-mediated reversal of the multidrug resistant phenotype
- Scanlon KJ, Ishida H, Kashani-Sabet M. Ribozyme-mediated reversal of the multidrug resistant phenotype. Proc Natl Acad Sci USA 1994;91:11123-7.
- (1994) Proc Natl Acad Sci USA , vol.91 , pp. 11123-11127
- Scanlon, K.J.¹ Ishida, H.² Kashani-Sabet, M.³

12
- 0029132791
- DNA analogues with nonphosphodiester backbones
- Nielsen PE. DNA analogues with nonphosphodiester backbones. Annu Rev Biophys Biomol Struct 1995;24:167-83.
- (1995) Annu Rev Biophys Biomol Struct , vol.24 , pp. 167-183
- Nielsen, P.E.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.